Etravirine adverse reactions: Difference between revisions

Jump to navigation Jump to search
No edit summary
mNo edit summary
 
(One intermediate revision by one other user not shown)
Line 7: Line 7:
The following adverse reactions are described in greater detail in other sections:
The following adverse reactions are described in greater detail in other sections:


Severe skin and hypersensitivity reactions [[Etravirine warnings and precautions|see Warnings and Precautions]].<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = INTELENCE (ETRAVIRINE) TABLET [JANSSEN PRODUCTS LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a9cbc29-9f15-4b24-8d86-206b82887f3d | publisher =  | date =  | accessdate =  }}</ref>
Severe skin and [[hypersensitivity]] reactions ([[Etravirine warnings and precautions|see Warnings and Precautions]]).<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = INTELENCE (ETRAVIRINE) TABLET [JANSSEN PRODUCTS LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6a9cbc29-9f15-4b24-8d86-206b82887f3d | publisher =  | date =  | accessdate =  }}</ref>
 


==References==
==References==

Latest revision as of 17:05, 5 January 2014

Etravirine
INTELENCE® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Adverse Reactions

The following adverse reactions are described in greater detail in other sections:

Severe skin and hypersensitivity reactions (see Warnings and Precautions).[1]

References

  1. "INTELENCE (ETRAVIRINE) TABLET [JANSSEN PRODUCTS LP]".

Adapted from the FDA Package Insert.